Insights

Strategic Growth MedSource is now part of Ergomed after a high-profile acquisition by Permira in 2023, signaling strengthened financial backing and expanded global reach. This presents an opportunity to position integrated CRO services to a broader client base and leverage cross-selling across Ergomed’s enhanced capabilities.

Therapeutic Focus The company has deep experience in oncology, neurology/CNS, and infectious diseases with participation in a large number of oncology trials. This alignment suggests targeting biotech and pharma sponsors with oncology and CNS programs looking for specialized CRO support and trial execution efficiency.

Global Footprint Active participation in 795+ clinical trials across 100+ countries indicates a broad geographic reach and versatility in study designs. This can be marketed to sponsors seeking global trial management, site network access, and regional regulatory navigation.

Operational Excellence Awards for communication and a client-centric, transparent process emphasize reliability and collaboration. This differentiator can be leveraged to win programs where sponsor relationships and trial subject experience are critical to retention and success.

Growth levers Recent acquisitions including Panacea Pharma Projects and Ashfield Pharmacovigilance expand capabilities in project management and safety/pharmacovigilance. This opens opportunities for bundled or expanded services, including end-to-end trial support and post-marketing safety setups.

MedSource (now Ergomed) Tech Stack

MedSource (now Ergomed) uses 8 technology products and services including cdnjs, Microsoft Excel, Twemoji, and more. Explore MedSource (now Ergomed)'s tech stack below.

  • cdnjs
    Content Delivery Network
  • Microsoft Excel
    Editors
  • Twemoji
    Font Scripts
  • jQuery Migrate
    Javascript Libraries
  • Microsoft
    Miscellaneous
  • Yoast SEO
    Search Engines
  • reCAPTCHA
    Security
  • Microsoft Teams
    Team Collaboration

Media & News

MedSource (now Ergomed)'s Email Address Formats

MedSource (now Ergomed) uses at least 2 format(s):
MedSource (now Ergomed) Email FormatsExamplePercentage
FLast@medsource.comJDoe@medsource.com
84%
First.Last@medsource.comJohn.Doe@medsource.com
14%
FirstLast@medsource.comJohnDoe@medsource.com
2%
First.Last@ergomedplc.comJohn.Doe@ergomedplc.com
98%
First.Middle@ergomedplc.comJohn.Michael@ergomedplc.com
2%

Frequently Asked Questions

What is MedSource (now Ergomed)'s phone number?

Minus sign iconPlus sign icon
You can contact MedSource (now Ergomed)'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is MedSource (now Ergomed)'s official website and social media links?

Minus sign iconPlus sign icon
MedSource (now Ergomed)'s official website is ergomedplc.com and has social profiles on LinkedIn.

How much revenue does MedSource (now Ergomed) generate?

Minus sign iconPlus sign icon
As of July 2026, MedSource (now Ergomed)'s annual revenue is estimated to be $25M - $50M.

What is MedSource (now Ergomed)'s NAICS code?

Minus sign iconPlus sign icon
MedSource (now Ergomed)'s NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does MedSource (now Ergomed) have currently?

Minus sign iconPlus sign icon
As of July 2026, MedSource (now Ergomed) has approximately 78 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chief Financial Officer: C. C.Senior Vice President, Global Strategy & Development, Head Rare Disease Innovation Center: Z. I.Director - Operations: K. R.. Explore MedSource (now Ergomed)'s employee directory with LeadIQ.

What industry does MedSource (now Ergomed) belong to?

Minus sign iconPlus sign icon
MedSource (now Ergomed) operates in the Pharmaceutical Manufacturing industry.

What technology does MedSource (now Ergomed) use?

Minus sign iconPlus sign icon
MedSource (now Ergomed)'s tech stack includes cdnjsMicrosoft ExcelTwemojijQuery MigrateMicrosoftYoast SEOreCAPTCHAMicrosoft Teams.

What is MedSource (now Ergomed)'s email format?

Minus sign iconPlus sign icon
MedSource (now Ergomed)'s email format typically follows the pattern of FLast@medsource.com. Find more MedSource (now Ergomed) email formats with LeadIQ.

When was MedSource (now Ergomed) founded?

Minus sign iconPlus sign icon
MedSource (now Ergomed) was founded in 1997.
MedSource (now Ergomed) logo

MedSource (now Ergomed)

Pharmaceutical ManufacturingTexas, United States51-200 Employees

MedSource, now part of Ergomed, operates as a clinical research organization within the pharmaceutical sector, coordinating and overseeing clinical trials for biopharmaceutical partners. It specializes in oncology, neurology/CNS, and infectious diseases, and has contributed to more than 795 trials worldwide, with over 250 in oncology. The organization emphasizes strong relationships, flexible processes, and transparency at every stage to support complex studies across diverse disease states and patient populations. Based in Houston, Texas, the mid-sized firm has broad experience across therapeutic areas, product types, trial phases, and study designs. Its aim is to provide high-quality clinical trial support that aligns with client needs and fosters ongoing collaboration.

Section iconCompany Overview

Phone number
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1997
Employees
51-200

Section iconFunding & Financials

  • $25M - $50M

    MedSource (now Ergomed)'s revenue is estimated to be in the range of $25M - $50M

Section iconFunding & Financials

  • $25M - $50M

    MedSource (now Ergomed)'s revenue is estimated to be in the range of $25M - $50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.